FDA Approved: SKYTROFA — Supplemental Application (Ascendis Pharma Endocrinology, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SKYTROFA (lonapegsomatropin-tcgD) from Ascendis Pharma Endocrinology, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Skytrofa (lonapegsomatropin)

Snippet

SUPPL AP for SKYTROFA (LONAPEGSOMATROPIN-TCGD)